HPMA–Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2017-08-22

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1158/1535-7163.MCT-15-0995PMID 28830983PMCID PMC5847372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Folate-targeted nanoparticles for rheumatoid arthritis therapy.

  2016cited by this paper
• Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.

  2015cited by this paper
• The Evaluation of the Therapeutic Efficacy and Side Effects of a Macromolecular Dexamethasone Prodrug in the Collagen-Induced Arthritis Mouse Model

  2015cited by this paper
• PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism

  2015cited by this paper
• Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages

  2015cited by this paper
• Cancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival Rates

  2015cited by this paper
• Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment

  2014cited by this paper
• Nonlinear Growth Kinetics of Breast Cancer Stem Cells: Implications for Cancer Stem Cell Targeted Therapy

  2013cited by this paper
• Microenvironmental regulation of tumor progression and metastasis

  2013cited by this paper
• TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition.

  2013cited by this paper
• Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activation

  2013cited by this paper
• The role of tumor-associated macrophages in breast cancer progression

  2013cited by this paper
• Development of Polymeric Nanocarrier System for Early Detection and Targeted Therapeutic Treatment of Peri-Implant Osteolysis

  2013cited by this paper
• CSF-1R inhibition alters macrophage polarization and blocks glioma progression

  2013cited by this paper
• Clinical Significance of Folate Receptor β–expressing Tumor-associated Macrophages in Pancreatic Cancer

  2012cited by this paper
• Development of macromolecular prodrug for rheumatoid arthritis.

  2012cited by this paper
• Early detection and treatment of wear particle-induced inflammation and bone loss in a mouse calvarial osteolysis model using HPMA copolymer conjugates.

  2011cited by this paper
• Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition.

  2011cited by this paper
• The bone, the joints and the Balm of Gilead.

  2011cited by this paper
• Pharmacokinetic and Biodistribution Studies of N -(2-Hydroxypropyl)methacrylamide (HPMA) Copolymer-Dexamethasone Conjugates in Adjuvant–induced Arthritis (AA) Rat Model

  2011cited by this paper
• Tumor entrained neutrophils inhibit seeding in the premetastatic lung.

  2011cited by this paper
• Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl)methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model.

  2010cited by this paper
• Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy

  2010cited by this paper
• Macrophages, innate immunity and cancer: balance, tolerance, and diversity.

  2010cited by this paper
• Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.

  2009cited by this paper
• Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates.

  2009cited by this paper
• Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers.

  2009cited by this paper
• Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages.

  2009cited by this paper
• “Re-educating” tumor-associated macrophages by targeting NF-κB

  2008cited by this paper
• Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis

  2007cited by this paper
• Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion.

  2006cited by this paper
• Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery

  2006cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• Macrophages: modulators of breast cancer progression.

  2004cited by this paper
• Functional Polymers from Novel Carboxyl-Terminated Trithiocarbonates as Highly Efficient RAFT Agents

  2002cited by this paper
• Design of novel bioconjugates for targeted drug delivery.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action.

  2000cited by this paper
• Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.

  1998cited by this paper
• International standing committee on human cytogenetic nomenclature

  1996cited by this paper
• Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.

  1992influential reference
• Tumoritropic and lymphotropic principles of macromolecular drugs.

  1989cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper
• Controlled biodegradability of polymers--a key to drug delivery systems.

  1984cited by this paper
• Heterogeneity of tumor cells from a single mouse mammary tumor.

  1978influential reference
• An international system for human cytogenetic nomenclature

  1978cited by this paper
• Soluble biomedical polymers.

  1977cited by this paper
• Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization

  1973cited by this paper
• A modified ninhydrin reagent for the photometric determination of amino acids and related compounds.

  1954cited by this paper

• Therapeutic advances in Tenosynovial giant cell Tumor: Targeting the CSF1/CSF1R axis.

  2025cites this paper
• Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer

  2024cites this paper
• Progress in reeducating tumor-associated macrophages in tumor microenvironment

  2024cites this paper
• Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity

  2024cites this paper
• Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy

  2023cites this paper
• Subverted macrophages in the triple-negative breast cancer ecosystem.

  2023cites this paper
• Anti-tumor effects of an ID antagonist with no observed acquired resistance

  2021cites this paper
• CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment

  2021cites this paper
• Molecular Perspective of Nanoparticle Mediated Therapeutic Targeting in Breast Cancer: An Odyssey of Endoplasmic Reticulum Unfolded Protein Response (UPRER) and Beyond

  2021cites this paper
• Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy

  2021cites this paper
• Nanoparticles targeting tumor-associated macrophages: A novel anti-tumor therapy

  2021cites this paper
• Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization

  2021cites this paper
• Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing.

  2020cites this paper
• RNA Interference and CRISPR Technologies: Technical Advances and New Therapeutic Opportunities

  2020cites this paper
• HPMA-based polymeric conjugates in anticancer therapeutics.

  2020cites this paper
• Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer

  2020cites this paper
• Recent Advances in Nanomedicines for Multiple Sclerosis Therapy.

  2020cites this paper
• Nanomedicine enables spatiotemporally regulating macrophage-based cancer immunotherapy.

  2020cites this paper
• Anti-tumor effects of an Id antagonist with no acquired resistance

  2020cites this paper
• Tailoring Nanomaterials for Targeting Tumor‐Associated Macrophages

  2019cites this paper
• Stimuli-responsive polymer-doxorubicin conjugate: Antitumor mechanism and potential as nano-prodrug.

  2019cites this paper
• Biorecognition: A key to drug-free macromolecular therapeutics.

  2019cites this paper
• Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment

  2018cites this paper